Antipsychotic Drugs Market Analysis By Generation (First, Second and Third), Therapeutic Application (Dementia, Bipolar disorder, Schizophrenia, Depression and Others), Top Manufacturers, Share Value, Competitive Landscape, Forecast To 2022
Global Antipsychotic Drugs Market size worth USD 18.5 Billion with growing at a 4.3% CAGR between 2017 and 2022. Psychosis is a collective term used to cover are a group of disorders that are regarding the serious distortion of behavior, thought, recognition of reality, and perception. Drugs that are useful for treating psychosis are called antipsychotic drugs.
Antipsychotic drugs market is expected to witness significant growth due to unmet medical needs of mental disorder patients. Assaying the market structure, this report accounts the future growth potential of the market. It characterizes the strategies of the topmost market players in the market and supports the competitive developments like research & developments (R&D), mergers & acquisitions, new product developments, and joint ventures, in the market.
Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/2784
Antipsychotic Drugs Market Key Players:
Top Key Companies in the global antipsychotic drugs market AstraZeneca (UK), Bristol-Myers Squibb (USA), Eli Lilly and Company (USA), GlaxoSmithKline PLC (UK), Johnson & Johnson (USA), and Pfizer Inc. (USA).
Antipsychotic Drugs Market Segmentation:
The global antipsychotic drugs market segmentation encompasses generations and therapeutic applications. MRFR’s take on the market surveys various facets of the market in-depth.
Global antipsychotic drugs market segmented based on generations include, first generation, second generation, and third generation.
Based on therapeutic applications, the antipsychotic drugs market has been segmented into bipolar disorder, dementia, depression, schizophrenia, and others.
Antipsychotic Drugs Market Regional Insights:
A geographical outlining of the global antipsychotic drugs market covers the Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA).
The Americas is the largest regional antipsychotic drugs market share as North America alone holds the potential of being a dominant market due to heavy investment in the R&D related to medicines and drugs. Due to technological advancements and availability of advanced medical facilities, North America is a bigger regional antipsychotic drugs market size than South America. USA and Canada generate maximum market revenue in this region. Many important key market players are based in the USA. Two most important market driving factors in this region are excellent reimbursements scenario in the USA and the rapid uptake of new drug molecules. Most of the crucial market players are based in the USA.
Europe is the second-largest regional antipsychotic drugs market share due to the high density of population and other reasons being the same as in North America. The most powerful country-specific markets in Europe are France, Germany, Italy, Spain, and the UK. An inspection of the remaining countries in Europe featured in this report speculate the huge contribution to market revenue from some other countries in this region.
During the forecast period, the Asia Pacific region can be the fastest growing regional market high density of population, improving healthcare facilities, and government efforts to improve healthcare, especially in China and India. Other pivotal country-specific markets in this region are Japan and South Korea. An observation of the remaining countries in the Asia Pacific region featured in this report calculates the huge addition to market revenue from some other countries.
The MEA region holds the lowest share in the global antipsychotic drugs market due to poor medical facilities and lack of skilled professionals.
Latest Industry News
- ACADIA Pharmaceuticals Inc. has announced its Phase 3 HARMONY study. This is going to be a double-blind, placebo-controlled relapse prevention trial that would evaluate pimavanserin for the treatment of dementia-related psychosis.
Browse the market data and information spread across 84 pages with data tables and figures of the report “Antipsychotic Drugs Market Research Report- Global Forecast to 2022” in depth alongside table of content (TOC) at: https://www.marketresearchfuture.com/reports/antipsychotic-drugs-market-2784
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
